Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study

These preliminary findings, occurring at doses low by current treatment standards, suggest that close electrocardiographic monitoring is warranted when prescribing ziprasidone to children, particularly at higher doses or when combined with other QTc-prolonging agents.